Martin Guillemaud

Martin Guillemaud

Auto-generated profile, based on publicly available information

Martin Guillemaud

Paris Brain Institute

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
MGMartin Guillemaud
Martin Guillemaud
MCMario Chavez
Mario Chavez
Firas KobeissyFiras Kobeissy
Firas Kobeissy
AVAnnamaria Vezzani
Annamaria Vezzani
AJAnthony D. Jimenez
Anthony D. Jimenez
AHAurélie Hanin
Aurélie Hanin
Emerging evidence suggests that immune dysregulation plays a pivotal role in triggering cryptogenic new-onset refractory status epilepticus (c-NORSE), prompting a consensus on early initiation of immunotherapy. However, despite similar timing of administration, responses to immunotherapies have been varied and unpredictable, suggesting the presence of heterogeneous underlying mechanisms. The aim of this study was to identify distinct inflammatory response subtypes in patients with c-NORSE by analyzing their cytokine profiles. Insights into underlying mechanisms were sought to understand the pathophysiology and guide personalized therapies to improve patient outcomes. Sixty-two patients with c-NORSE were included. A comprehensive panel of 96 cytokines was analyzed in serum samples. Patients were clustered based on their cytokine profiles using the Louvain algorithm, an unsupervised graph-based clustering method. The identified clusters of patients were compared regarding cytokine levels and clinical features. Protein pathway analysis was used to explore the biological relevance of the inflammatory markers within each cluster. Patients with c-NORSE were compared with control patients (n = 18) and patients with other forms of refractory SE (n = 45). Compared with controls, patients with c-NORSE exhibited significant differences in 33 cytokines. Pathway analysis revealed dysregulations in chemotaxis and neutrophil recruitment and migration, highlighting the importance of innate immunity in patients with c-NORSE. Within the c-NORSE cohort, 3 clusters of patients emerged: cluster A, lacking specific inflammatory markers; cluster B, with a much stronger innate-immunity cytokine-driven inflammatory response compared with clusters A and C; and cluster C, defined by dysregulated autoimmune processes. Notably, patients in cluster B showed a statistically significant elevation of innate immune-related proinflammatory cytokines associated with leukocyte recruitment and degranulation. By contrast, those in cluster C showed activation of Janus kinase signal transducer and activator of transcription (JAK-STAT) pathways, suggesting autoimmune mechanisms. Patients in clusters B and C demonstrated varied responses to immunotherapies, with cluster C patients showing favorable outcomes after multiple immunotherapies. The identification of distinct inflammatory subgroups in c-NORSE suggests that variations in the underlying immune mechanisms contribute to differential treatment responses. These findings underscore the importance of personalized therapeutic strategies, potentially targeting specific inflammatory pathways, to optimize clinical outcomes in this challenging condition.

1 June 2024 in Chaos: An Interdisciplinary Journal of Nonlinear Science
Verified
Journal Article
Open access
PDF file
ALA. Longhena
A. Longhena
MGM. Guillemaud
M. Guillemaud
MCM. Chavez
M. Chavez
This paper introduces two novel scores for detecting local perturbations in networks. For this, we consider a non-Euclidean representation of networks, namely, their embedding onto the Poincaré disk model of hyperbolic geometry. We numerically evaluate the performances of these scores for the detection and localization of perturbations on homogeneous and heterogeneous network models. To illustrate our approach, we study latent geometric representations of real brain networks to identify and quantify the impact of epilepsy surgery on brain regions. Results suggest that our approach can provide a powerful tool for representing and analyzing changes in brain networks following surgical intervention, marking the first application of geometric network embedding in epilepsy research.

2 April 2025 in Physical Review E
Verified
Journal Article
Closed access
ALAlice Longhena
Alice Longhena
MGMartin Guillemaud
Martin Guillemaud
FFFabrizio De Vico Fallani
Fabrizio De Vico Fallani
RMRaffaella Migliaccio
Raffaella Migliaccio
MCMario Chavez
Mario Chavez
Graph-theoretical methods have proven valuable for investigating alterations in both anatomical and functional brain connectivity networks during Alzheimer's disease (AD). Recent studies suggest that representing brain networks in a suitable geometric space can better capture their connectivity structure. This study introduces a novel approach to characterize brain connectivity changes using low-dimensional, informative representations of networks in a latent geometric space. Specifically, the networks are embedded in a polar representation of the hyperbolic plane, the hyperbolic disk. Here, we used a geometric score, entirely based on the computation of distances between nodes in the latent space, to measure the effect of a perturbation on the nodes. Precisely, the score is a local measure of distortion in the geometric neighborhood of a node following a perturbation. The method is applied to a brain network dataset of patients with AD and healthy participants, derived from diffusion-weighted (DWI) and functional magnetic resonance (fMRI) imaging scans. We show that, compared with standard graph measures, our method more accurately identifies the brain regions most affected by neurodegeneration. Notably, the abnormalities detected in memory-related and frontal areas are robust across multiple brain parcellation scales. Finally, our findings suggest that the geometric perturbation score could serve as a potential biomarker for characterizing the progression of the disease.

22 August 2025 in Epilepsia
Verified
Journal Article
Open access
MGMartin Guillemaud
Martin Guillemaud
AHAurélie Hanin
Aurélie Hanin
JRJames J. Riviello
James J. Riviello
MCMario Chavez
Mario Chavez
ABAyush Batra
Ayush Batra
YLYi-Chen Lai
Yi-Chen Lai
Objective: We investigated whether complete blood count (CBC) analyses during intensive care unit stay could predict 12‐month outcomes in patients with cryptogenic febrile infection–related epilepsy syndrome (FIRES), a subset of new‐onset refractory status epilepticus (NORSE). Methods: Outcomes at 12 months were classified as “unfavorable” (Glasgow Outcome Score [GOS] 1–3) or “favorable” (GOS 4–5). Demographic, clinical, and serial CBC data were collected across treatment phases: (1) no immunotherapy (before initiation or no treatment), (2) first‐line immunotherapy, and (3) second‐line immunotherapy. For each treatment phase, predictive models stratified outcomes based on CBC features using decision tree regression, with separate models for adults and children. Model performance was tested using a leave‐one‐patient‐out approach. Results: We studied 63 patients (34 adults, 29 children) from 12 centers. Unfavorable outcomes occurred in 18 adults and 12 children. Children were more likely to receive second‐line immunotherapy. We analyzed 1530 CBCs (adults: 997 CBCs, including 539 for unfavorable outcomes; children: 533 CBCs, including 415 for unfavorable outcomes). Subgroup analyses revealed differences in CBC levels according to the outcomes and the treatment received. Adults with unfavorable outcomes notably had higher neutrophil‐to‐lymphocyte ratios (NLRs) and monocyte‐to‐lymphocyte ratios (MLRs), whereas children with unfavorable outcomes had higher red cell distribution width. NLRs and MLRs increased when CBCs were collected after the initiation of immunotherapy for both adults and children. The variables of interest differed in the different predictive models but always included the proportion of at least one subtype of leukocyte. Prediction accuracy with our models was higher in children (87% overall, with the best performance in no‐treatment and first‐line phases) than in adults (83% overall, with the best performance during/after the initiation of second‐line). Significance: Findings suggest the potential for standard CBCs to serve as a rapid, accessible tool for early prognostication in cryptogenic FIRES, particularly in children.

27 May 2025 in Physical Review Research
Verified
Journal Article
Open access
MGMartin Guillemaud
Martin Guillemaud
LCLouis Cousyn
Louis Cousyn
VNVincent Navarro
Vincent Navarro
MCMario Chavez
Mario Chavez
The evidence indicates that intracranial electroencephalographic connectivity, as estimated from daily resting state recordings from epileptic patients, may be capable of identifying preictal states. In this study, we employed hyperbolic embedding of brain networks to capture nontrivial patterns that discriminate between connectivity networks from days with (preictal) and without (interictal) seizure. A statistical model was constructed by combining hyperbolic geometry and machine learning tools, which allowed for the estimation of the probability of an upcoming seizure. The results demonstrated that representing brain networks in a hyperbolic space enabled an accurate discrimination (85%) between interictal (no seizure) and preictal (seizure within the next 24 hours) states. The proposed method also demonstrated excellent prediction performances, with an overall accuracy of 87% and an F1 score of 89% (mean Brier score and Brier skill score of 0.12 and 0.37, respectively). In conclusion, our findings indicate that representations of brain connectivity in a latent geometry space can reveal a daily and reliable signature of the upcoming seizure(s), thus providing a promising biomarker for seizure forecasting.

16 February 2026 in Epilepsia
Verified
Journal Article
Open access
AHAurélie Hanin
Aurélie Hanin
CMClémence Marois
Clémence Marois
MGMartin Guillemaud
Martin Guillemaud
MCMario Chavez
Mario Chavez
LCLéa Cosme
Léa Cosme
VNVincent Navarro
Vincent Navarro
Objective: Cryptogenic new onset refractory status epilepticus (cNORSE) carries high risks of long‐term disability and post‐NORSE epilepsy, but mechanisms remain unclear. We aimed to assess the predictive value of inflammatory and brain injury biomarkers and determine whether immune disturbances persist in the chronic phase. Methods: We enrolled 93 cNORSE patients from the Pitié‐Salpêtrière Hospital and the Yale NORSE/FIRES biorepository (2013–2025). Serum and cerebrospinal fluid (CSF) samples were collected during status epilepticus (SE), with outcomes assessed 6–12 months after resolution. To investigate post‐cNORSE epilepsy, we compared 39 post‐cNORSE patients (25 with paired acute samples) to 40 patients with temporal lobe epilepsy due to hippocampal sclerosis (TLE‐HS) and 20 with chronic immune‐mediated encephalitis. Results: During cNORSE, elevated innate cytokines (serum CXCL8, CCL2; CSF IL‐6, CXCL8, CCL2, MIP‐1α, G‐CSF) and brain injury biomarkers (serum and CSF neurofilament light chain [NfL], CSF neuron‐specific enolase) correlated with worse functional outcomes. Multivariate models demonstrated that adding serum NfL to cytokines improved poor outcome prediction (area under the curve = .75). In contrast, no acute biomarker predicted post‐cNORSE epilepsy, which was instead associated with prolonged SE, magnetic resonance imaging abnormalities, and the need for more intensive treatment. In paired analyses, most serum cytokines normalized during the chronic phase, particularly IL‐6, IL‐10, and IL‐1β, although new adaptive immune disturbances (IL‐17A, IL‐12p70, TNFα) appeared in 20% of patients. No chronic elevations of innate cytokines were observed in post‐cNORSE patients. Conversely, elevated age‐adjusted NfL levels were more frequent in post‐cNORSE epilepsy (64%) than encephalitis (45%) and TLE‐HS (20%), ( p < .001), with elevated NfL levels correlating with poor functional outcomes ( p = .019). Significance: Innate immune activation is a hallmark of acute cNORSE but largely resolves in the chronic phase, arguing against persistent innate inflammation as the driver of post‐cNORSE epilepsy. In contrast, persistently elevated NfL levels suggest ongoing axonal injury, potentially contributing to poor outcomes. Integrating inflammatory and neuroaxonal injury biomarkers may improve risk stratification and guide long‐term management.